Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST)

Journal of Thoracic Disease

Volumn 4, Issue 1, 2012, Pages 40-47

  Higashiyama, Masahiko ^a   Okami, Jiro ^a   Maeda, Jun ^a   Tokunaga, Toshiteru ^a   Fujiwara, Ayako ^a   Kodama, Ken ^a   Imamura, Fumio ^a   Kobayashi, Hisayuki ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Nitta Gelatin Inc   (Japan)

Author keywords

Chemosensitivity Test; Chemotherapy; Collagen gel droplet embedded culture drug test (CD DST); Metastatic Tissue; Non small cell lung cancer (NSCLC)

Indexed keywords

EID: 84861980920     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2011.05.02     Document Type: Article

References (30)

1. Date H, Kiura K, Ueoka H, Tabata M, Aoe M, Andou A, et al. Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer. Br J Cancer 2002;86:530-3.
2. Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, et al. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 2007;18:317-23.
3. Akamine S, Nakamura Y, Oka T, Soda H, Taniguchi H, Fukuda M, et al. Induction chemotherapy with cisplatin, vinorelbine, and mitomycin-C followed by surgery for patients with pathologic N2 non-small-cell lung cancer. Clin Lung Cancer 2008;9:44-50.
4. Kern DH. Heterogeneity of drug resistance in human breast and ovarian cancers. Cancer J Sci Am 1998;4:41-5.
5. Slack NH, Bross ID. The influence of site of metastasis on tumour growth and response to chemotherapy. Br J Cancer 1975;32:78-86.
6. Kamby C, Vestlev PM, Mouridsen HT. Site-specific effect of chemotherapy in patients with breast cancer. Acta Oncol 1992;31:225-9.
7. Nicolson GL. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metasatasis Rev 2006;12:325-43.
8. Wu J. Apoptosis and angiogenesis: two promising tumor markers in breast cancer (review). Anticancer Res 1996;16:2233-9.
9. Glinsky GV, Glinsky VV, Ivanova AB, Hueser CJ. Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett 1997;115:185-93.
10. Dong X, Guan J, English JC, Flint J, Yee J, Evans K, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 2010;16:1442-51.
11. Hoffman RM. In vitro sensitivity assays in cancer: a review, analysis, and prognosis. J Clin Lab Anal 1991;5:133-43.
12. Kondo T, Imamura T, Ichihashi H. In vitro test for sensitivity of tumor to carcinostatic agents. Gann 1966;57:113-21.
13. Bertelsen CA, Sondak VK, Mann BD, Korn EL, Kern DH. Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations. Cancer 1984;53:1240-5.
14. Shaw GL, Gazdar AF, Phelps R, Steinberg SM, Linnoila RI, Johnson BE, et al. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem Suppl 1996;24:173-85.
15. Kobayashi H, Higashiyama M, Minamigawa K, Tanisaka K, Takano T, Yokouchi H, et al. Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification. Jpn J Cancer Res 2001;92:203-10.
16. Kobayashi H. Development of a new in vitro chemosensitivity test using collagen gel droplet embedded culture and image analysis for clinical usefulness. Recent Results Cancer Res 2003;161:48-61.
17. Kobayashi H. Collagen gel droplet culture method to examine in vitro chemosensitivity. Methods Mol Med 2005;110:59-67.
18. Higashiyama M, Kodama K, Yokouchi H, Takami K, Nakagawa H, Imamura F, et al.. Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response. Oncol Rep 2001;8:279-83.
19. Kawamura M, Gika M, Abiko T, Inoue Y, Oyama T, Izumi Y, et al. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST). Cancer Chemother Pharmacol 2007;59:507-13.
20. Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Imamura F, et al. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients. Lung Cancer 2010;68:472-7.
21. Noda T, Higashiyama M, Oda K, Higaki N, Takami K, Okami J, et al. Mucoepidermoid carcinoma of the thymus treated by multimodality therapy: a case report. Ann Thorac Cardiovasc Surg 2006;12:273-8.
22. Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Takami K, et al. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application. Ann Thorac Cardiovasc Surg 2008;14:355-62.
23. The Japan Lung Cancer Society. General rule for clinical and pathological record of lung cancer. 6th ed. Tokyo, Japan: Kanehara-Shuppan; 2003.
24. Yoshimasu T, Oura S, Hirai I, Tamaki T, Kokawa Y, Hata K, et al. Data acquisition for the histoculture drug response assay in lung cancer. J Thorac Cardiovasc Surg 2007;133:303-8.
25. Tanahashi M, Niwa H, Yukiue H, Suzuki E, Haneda H, Yoshii N. Adjuvant chemotherapy based on the in vitro hisotculture drug response assay for non-small cell lung cancer improves survival. J Thorac Oncol 2010;5:1376-81.
26. Moon YW, Choi SH, Kim YT, Sohn JH, Chang J, Kim SK, et al. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer. Cancer 2007;109:1829-35.
27. Furukawa T, Kubota T, Tanino H, Oura S, Yuasa S, Murate H, et al. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay. Anticancer Res 2000;20:3657-8.
28. Sekine I, Minna JD, Nishio K, Tamura T, Saijo N. A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer. J Thorac Oncol 2007;2:845-53.
29. Glaysher S, Yiannakis D, Gabriel FG, Johnson P, Polak ME, Knight LA, et al. Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). BMC Cancer 2009;9:300.
30. Inaba M, Tashiro T, Sato S, Ohnishi Y, Tanisaka K, Kobayashi H, et al. In vitro-in vivo correlation in anticancer drug sensitivity test using AUC-based concentrations and collagen gel droplet-embedded culture. Oncology 1996;53:250-7.